Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
Status:
Completed
Trial end date:
2016-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if either a targeted type of talk therapy (Phase I)
or medication, Wellbutrin, (Phase II) improve sleep disturbance and/or fatigue in individuals
with Inflammatory Bowel Disease (IBD).